Date post: | 03-Apr-2018 |
Category: |
Documents |
Upload: | tadiwanashe-logan |
View: | 217 times |
Download: | 0 times |
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 1/34
DOSEDOSE – –RESONSE CURVERESONSE CURVE
1.1. Graded doseGraded dose--response curveresponse curve
2. Quantal (all or none ) curve2. Quantal (all or none ) curve
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 2/34
Graded DoseGraded Dose--response Curveresponse Curve
1.1. Response is continuous and gradualResponse is continuous and gradual..
2.2. Curve is usually sigmoid in shape ( LogCurve is usually sigmoid in shape ( Log
dose or concentration).dose or concentration).
3.3. used to calculateused to calculateED50ED50
PotencyPotency
EfficacyEfficacy
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 3/34
MEDIAN EFFECTIVE DOSE (ED50 ).MEDIAN EFFECTIVE DOSE (ED50 ).
is a dose of the drug that gives ais a dose of the drug that gives a
response equals to 50% of the maximalresponse equals to 50% of the maximal
response.response.
is a measure of theis a measure of the potencypotency..
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 4/34
POTENCYPOTENCY
IsIs inverselyinversely proportional to ED 50.proportional to ED 50.
Is a measure (in weight) of the amount of Is a measure (in weight) of the amount of
the drug required to produce an action of the drug required to produce an action of a given magnitude (a given magnitude (50% of the maximal50% of the maximal
response = ED50response = ED50).).
The smaller is the EC50, the more potentThe smaller is the EC50, the more potent
is the drug.is the drug.
Efficacy is more important than potency.Efficacy is more important than potency.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 5/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 6/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 7/34
EFFICACYEFFICACY
Depends on the number of drugDepends on the number of drug--
receptors formed.receptors formed.
Efficacy is more important than potency.Efficacy is more important than potency.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 8/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 9/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 10/34
Quantal (all or none ) curveQuantal (all or none ) curve
Shows the effect of the magnitude of Shows the effect of the magnitude of
the dose on the proportion of patientsthe dose on the proportion of patientsresponding (responding (Quantal responsesQuantal responses).).
Used to determine doses to whichUsed to determine doses to which
most population respond.most population respond.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 11/34
Quantal (all or none ) curveQuantal (all or none ) curve
MEDIAN EFFECTIVE DOSE (ED50 ).MEDIAN EFFECTIVE DOSE (ED50 ).
is a dose of the drug that gives responseis a dose of the drug that gives response
in 50% of patients.in 50% of patients.
MEDIAN LETHAL DOSE ( LD 50 or TD 50)MEDIAN LETHAL DOSE ( LD 50 or TD 50)
is the dose of a drug required to produceis the dose of a drug required to producetoxicity in 50 % of patients.toxicity in 50 % of patients.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 12/34
THERAPEUTIC INDEXTHERAPEUTIC INDEX (TI)(TI)
Therapeutic index =Therapeutic index = LD50LD50
ED50ED50
Is a measure of safetyIs a measure of safety
Large value a wide margin of safety.Large value a wide margin of safety.PenicillinPenicillin
Small value a narrow margin of Small value a narrow margin of safetysafety warfarinwarfarin
If (TI) is equal to or less than one,If (TI) is equal to or less than one,
drug isdrug is ??????
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 13/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 14/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 15/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 16/34
AntagonistAntagonist
TypesTypes
¾¾ Physiological antagonist.Physiological antagonist.
¾¾ Chemical antagonist.Chemical antagonist.
¾¾ Pharmacological antagonist.Pharmacological antagonist.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 17/34
AntagonismAntagonism
¾¾ Physiological antagonism.Physiological antagonism.
¾¾
Chemical antagonism.Chemical antagonism.
¾¾ Pharmacological antagonism.Pharmacological antagonism.
CompetitiveCompetitive → Reversible.Reversible.
NonNon--competitivecompetitive → Irreversible.Irreversible.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 18/34
••Drug AntagonismDrug Antagonism
Chemical AntagonismChemical Antagonism
¾¾Simple chemical reaction.Simple chemical reaction.¾¾No receptor.No receptor.
ExamplesExamples¾¾Antacid &Antacid & tetracyclinestetracyclines..
¾¾ Heparin & proteamine sulfateHeparin & proteamine sulfate
¾¾ Iron & Deferoxamine.Iron & Deferoxamine.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 19/34
Physiological AntagonismPhysiological Antagonism
¾¾Physiological effect is antagonized.Physiological effect is antagonized.¾¾Drugs acting on different receptors:Drugs acting on different receptors:
¾¾NoradrenalineNoradrenaline → VasoconstrictionVasoconstriction → ↑ BP.BP.
¾¾HistamineHistamine → Relax vascular smoothRelax vascular smooth
musclemuscle→ ↓BPBP
¾¾Noradrenaline is used in anaphylactic shockNoradrenaline is used in anaphylactic shockto raise BP.to raise BP.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 20/34
PharmacologicalPharmacological AntagonismAntagonism
Two drugs compete for the same receptor.Two drugs compete for the same receptor.
The antagonist partially or completely preventsThe antagonist partially or completely prevents
the pharmacological agonist effect.the pharmacological agonist effect.Pharmacological antagonistPharmacological antagonist
¾¾CompetitiveCompetitiveReversibleReversible
¾¾NonNon--competitivecompetitive
IrreversibleIrreversible
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 21/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 22/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 23/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 24/34
Competitive AntagonistCompetitive Antagonist
¾¾ The antagonist dissociates rapidlyThe antagonist dissociates rapidlyfrom the receptor.from the receptor.
¾¾ The antagonist effect can be overcomeThe antagonist effect can be overcomeby increasing the agonist concentration.by increasing the agonist concentration.
¾¾ The doseThe dose--response curve is shifted toresponse curve is shifted to
right.right.
¾¾ DoseDose--Response curve is parallel.Response curve is parallel.
¾¾EmaxEmax is maintained.is maintained.
¾¾ e.g. acetylcholine and atropine.e.g. acetylcholine and atropine.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 25/34
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 26/34
Irreversible noncompetitive AntagonistIrreversible noncompetitive Antagonist
¾¾The antagonist dissociates very slowly or The antagonist dissociates very slowly or not at all from the receptor .not at all from the receptor .
¾¾The action of antagonist cannot beThe action of antagonist cannot beovercome by increasing the agonistovercome by increasing the agonist
concentration .concentration .
¾¾ The doseThe dose--response curve is shifted toresponse curve is shifted to
right.right.
¾¾ The two curves are not parallel.The two curves are not parallel.
¾¾EmaxEmax is not maintained.is not maintained.
¾¾PhenoxybenzaminePhenoxybenzamine ..
ProdrugProdrug
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 27/34
ProdrugProdrug
A drug that is pharmacologically inactive but isA drug that is pharmacologically inactive but is
chemically changed into active form in the bodychemically changed into active form in the bodyby the action of enzymes.by the action of enzymes.
DoseDose
The amount of a drug to produce an effect.The amount of a drug to produce an effect.
Therapeutic DoseTherapeutic Dose
The dose required to produce therapeutic effect.The dose required to produce therapeutic effect.
Toxic DoseToxic DoseThe dose which produce toxic effect.The dose which produce toxic effect.
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 28/34
Variation in drug responseVariation in drug response
Drug resistanceDrug resistance
intoleranceintolerance
ToleranceTolerance
TachyphylaxisTachyphylaxis
IdiosyncrasyIdiosyncrasy
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 29/34
DRUG RESISTANCEDRUG RESISTANCE
The loss of the effectiveness of The loss of the effectiveness of antimicrobial or antitumour drugs.antimicrobial or antitumour drugs.
INTOLERANCE (HYPEINTOLERANCE (HYPE--RACTIVITY)RACTIVITY)
¾¾ Increase in response within theIncrease in response within the
therapeutic dose.therapeutic dose.
¾¾ Orthostatic hypotension after Orthostatic hypotension after
Chlorpromazine (tranquilizer).Chlorpromazine (tranquilizer).
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 30/34
TOLERANCETOLERANCE
A gradual decrease in response toA gradual decrease in response to
repeated administration of a drug.repeated administration of a drug.
Slow in onset (takes days or weeks toSlow in onset (takes days or weeks to
develop).develop).
Original effect can be produced byOriginal effect can be produced by
increasing the dose.increasing the dose.
e.g. alcohols, morphine, barbiturates.e.g. alcohols, morphine, barbiturates.
TACHYPHYLAXISTACHYPHYLAXIS
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 31/34
TACHYPHYLAXISTACHYPHYLAXIS
A decrease in response to the rapidlyA decrease in response to the rapidlyrepeated administration of a drug.repeated administration of a drug.
Rapid in onset.Rapid in onset.
Original effect cannot be reproduced evenOriginal effect cannot be reproduced even
with a larger dose of the drug.with a larger dose of the drug.
e.g. Be.g. B--agonists, ephedrine, amphetamine,agonists, ephedrine, amphetamine,
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 32/34
RECEPTOR DESENSITIZATIONRECEPTOR DESENSITIZATION
DefinitionDefinition
Changes in the responsiveness of theChanges in the responsiveness of the
receptor upon repeated or continuousreceptor upon repeated or continuous
administration of the drug.administration of the drug.
Causes of desensitizationCauses of desensitization
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 33/34
Causes of desensitizationCauses of desensitization
¾¾Excessive stimulation of the receptorsExcessive stimulation of the receptors
¾¾Genetic causes.Genetic causes.
¾¾
Down regulation of receptors.Down regulation of receptors.¾¾ Enzyme inductionEnzyme induction
7/29/2019 General Pharmacology (Pharmacodynamics- II)
http://slidepdf.com/reader/full/general-pharmacology-pharmacodynamics-ii 34/34
Causes of desensitizationCauses of desensitization
¾¾ Genetic causes.Genetic causes.
¾¾Down regulation of receptors.Down regulation of receptors.
(( Decrease in the total number of receptorsDecrease in the total number of receptorsavailableavailable).).
¾¾Enzyme inductionEnzyme induction
TypesTypes¾¾ ToleranceTolerance
¾¾ TachyphylaxisTachyphylaxis